Join to View Full Profile
Brigham Womens Hospital75 Francis St Renal Div MRB4Boston, MA 02115
Phone+1 617-732-6383
Dr. Paik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2007 - 2011
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2004 - 2007- Icahn School of Medicine at Mount SinaiClass of 2004
Certifications & Licensure
MA State Medical License 2007 - 2025
NY State Medical License 2005 - 2007
Publications & Presentations
PubMed
- Evidence on the benefits of statins for CVD prevention in older adults with CKD.Ariela R Orkaby, Julie M Paik
The Lancet. Healthy Longevity. 2025-03-01 - Comparative Effectiveness of Individual Sodium-Glucose Cotransporter 2 Inhibitors.HoJin Shin, Julie M Paik, Brendan M Everett, Elyse DiCesare, Caroline Alix
JAMA Internal Medicine. 2025-03-01 - Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study.Helen Tesfaye, Julie M Paik, Heidi Zakoul, Niklas Schmedt, Deborah J Wexler
Diabetes, Obesity & Metabolism. 2025-02-28
Press Mentions
SGLT2 Inhibitors vs DPP4 Inhibitors Lower Hyperkalemia Risk in CKD+T2D CasesAugust 15th, 2024- Empagliflozin May Reduce Stone RiskNovember 5th, 2022
- SGLT2 Inhibitor Use Rising in Patients with DKDAugust 23rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
